Marinomed Biotech AG

Declaration of Voting Results & Voting Rights Announcements • Oct 18, 2019

Publication Date: 18.10.2019 17:01 EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Overview 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Acquisition or disposal of voting rights 3. Person subject to notification obligation Name: Privatstiftung für die Standorterhaltung in Oberösterreich City: Linz Country: Österreich 4. Name of shareholder(s): Invest Unternehmensbeteiligungs Aktiengesellschaft 5. Date on which the threshold was crossed or reached: 18.10.2019

1. Total positions

____________
		% of voting
	% of voting			rights through Total of both Total number of
	rights attached financial/other in % (7.A +			voting rights
	to shares (7.A) instruments		7.B)	of issuer
		(7.B.1 + 7.B.2)
				__ __ __ __ __
Resulting
situation on
the date on
which threshold	3.24 %	0.00 %	3.24 %	1 469 772
was crossed /
reached
__ __ __ __ __
Position of
previous
notification	8.70 %		8.70 %
(if applicable)
				__ __ __ __ __

Details

1. Notified details of the resulting situation:

A: Voting rights attached to shares ____________
	Number of voting rights			% of voting rights
	____ _____ Direct Indirect			Direct				Indirect
ISIN Code	(Sec 130 BörseG (Sec 133 BörseG (Sec 130 BörseG (Sec 133 BörseG
	2018)	2018)		2018)			2018)
ATMARINOMED6	___ ___ ___ ___ __	47 587						3.24 %
SUBTOTAL A	___ ___ ___ ___ __ 47 587 ___ _____ ________				3.24 %

______________________________________________________________________________

			____________
			Number of voting
			rights that may
			be
Type of			Expiration Date Exercise Period acquired if the	% of voting
instrument			instrument is	rights
			exercised
			___ ___ ___ ___ __
			___ ___ ___ ___ __
		SUBTOTAL B.1
			___ ___ ___ ___ __

2018	___________ B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG ___________
Type of instrument	Expiration Exercise Date	Period	Physical / Cash Settlement		Number of		voting rights % of voting rights
	__ _ __ _ _ _ __ _ __ _ _ _
	__ _ __ _ _ _		SUBTOTAL B.2

1. Information in relation to the person subject to the notification obligation: Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

	________________
				Financial/
			Shares	other
		Directly	held	instruments Total of
No.	Name	controlled directly		held	both (%)
		by No.	(%)	directly
				(%)
	__ ____ _ _ __ _
	Privatstiftung für die
1	Standorterhaltung in
	Oberösterreich
	__ ____ _ _ __ _
2	IAG Beteiligungen GmbH	1
	__ ____ _ _ __ _
	Invest
3	Unternehmensbeteiligungs	2	3.24 %		3.24 %
	Aktiengesellschaft
	__ ____ _ _ __ _

1. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights.

2. Additional comments: -

Further inquiry note:

Dr. Eva Prieschl-Grassauer Chief Scientific Officer, Marinomed Veterinärplatz 1, 1210 Vienna, Austria T +43 (0)1 250 77 4460 E-Mail: eva.prieschl@marinomed.com http://www.marinomed.com Roland Mayrl Managing Partner, Metrum Communications Bauernmarkt 10/19, 1010 Vienna, Austria T +43 (0) 1 504 69 87 331 E-Mail: r.mayrl@metrum.at http://www.metrum.at end of announcement euro adhoc

---

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English

Aussendung übermittelt durch euro adhoc The European Investor Relations Service